Julian Adams, Ph.D., of Infinity Pharmaceuticals Named Corporate Chair for The Leukemia & Lymphoma Society’s Light the Night

  Julian Adams, Ph.D., of Infinity Pharmaceuticals Named Corporate Chair for
  The Leukemia & Lymphoma Society’s Light the Night Walk

        Urges Local Businesses Take the First Step to Help Beat Cancer

Business Wire

NATICK, Mass. -- September 16, 2013

The Massachusetts chapter of The Leukemia & Lymphoma Society (LLS) named
Julian Adams, Ph.D., of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) as
corporate chair of its 2014 Light The Night^® Walk, LLS’s annual fundraising
event for cancer research and patient services. Dr. Adams serves as president,
research and development, at Infinity and is responsible for the full spectrum
of the company’s drug discovery, preclinical and clinical development strategy
and regulatory affairs activities.

LLS holds walks each fall in approximately 200 communities across the United
States and Canada. Participants at the walks carry illuminated balloons –
white for survivors, red for supporters, and gold to remember those who have
died – to honor and commemorate lives touched by blood cancer.

“Forming Light The Night Walk teams is a great way to build team spirit among
employees, raise awareness about the need for more blood cancer therapies and
recognize those who continue to be affected by these diseases,” said Dr.
Adams. “These same objectives – and our desire to continue our support of LLS
– led us to recently launch Infinity Pharmaceuticals’ “Sparks of Inspiration”
campaign. I am honored to serve as the chair of the 2014 Light The Night Walk
and look forward to helping more local businesses and corporations get their
employees involved.”

Prior to joining Infinity in 2003, Dr. Adams served as senior vice president,
drug discovery and development at Millennium Pharmaceuticals. In this
capacity, he held global responsibility for multiple drug discovery programs,
including the successful discovery and development of Velcade^® (bortezomib),
a proteasome inhibitor for two different blood cancers: multiple myeloma and
relapsed mantle cell lymphoma. He previously held senior management positions
with organizations such as LeukoSite, ProScript, Inc. and Boehringer
Ingelheim, where he successfully discovered the drug Viramune^® (nevirapine)
for HIV. Dr. Adams’ awards include the 2012 Warren Alpert Foundation Prize for
his role in the discovery and development of bortezomib, the 2012 C. Chester
Stock Award Lectureship from Memorial Sloan-Kettering Cancer Center, and the
2001 Ribbon of Hope Award for Velcade^® from the International Myeloma
Foundation.

The funds raised through corporate and individual contributions during the
Light The Night^® Walk help to find cures and better therapies for leukemia,
lymphoma, Hodgkin disease and myeloma. Donations also provide information,
education and support for patients and their families.

“Light The Night Walk gives hope to patients and their families and lets them
know they are not alone in their battle against cancer,” said Sharon Klein,
executive director of the Massachusetts chapter of the LLS.

To find out more about forming a team or participating in a Light The Night
walk, contact the Massachusetts Chapter at 508-810-1342, or
www.lightthenight.org

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society^® (LLS) is the world’s largest voluntary
health agency dedicated to blood cancer. The LLS mission:Cure leukemia,
lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of
patients and their families. LLS funds lifesaving blood cancer research around
the world and provides free information and support services.

Founded in 1949and headquartered in White Plains, NY, LLS
haschaptersthroughout the United States and Canada. To learn more, visit
www.LLS.org or contacttheInformation Resource Center at (800) 955-4572,
Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

About Infinity’s “Sparks of Inspiration” Campaign
Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company
dedicated to discovering, developing and delivering best-in-class medicines to
people with difficult-to-treat diseases. Throughout September, Infinity is
observing National Blood Cancer Awareness Month, joining patients, healthcare
providers and patient organizations in raising public awareness of blood
cancers and the need for continued research for novel treatment options. In
support of patients and their loved ones, Infinity is launching the Sparks of
Inspiration campaign. Infinity encourages the submission of stories along with
photos and illustrations honoring friends, family members or loved ones
affected by blood cancer. For each submission received, Infinity will make a
$10 donation to the Leukemia & Lymphoma Society, up to a total of $5,000.
Submissions can be made through Infinity’s website www.infi.com. Submissions
will be accepted through September 30, 2013.

Contact:

Leukemia & Lymphoma Society
Ahlea Isabella, 508-810-1311
Ahlea.Isabella@lls.org
 
Press spacebar to pause and continue. Press esc to stop.